November 24, 20091CytRx to Initiate Clinical Trial for Soft Tissue Cancer Drug CytRx, a biopharmaceutical research and development company, has announced plans to initiate a Phase II clinical trial for its drug candidate INNO-206 to treat patients who suffer from advanced, treatment-resistant soft tissue sarcoma.
